131 related articles for article (PubMed ID: 2715006)
1. Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using 131I-B72.3.
Mansi L; Panza N; Lastoria S; Pacilio G; Salvatore M
Int J Rad Appl Instrum B; 1989; 16(2):127-35. PubMed ID: 2715006
[TBL] [Abstract][Full Text] [Related]
2. A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary report.
Lastoria S; D'Amico P; Mansi L; Giordano GG; Rossiello R; Schlom J; Pace E; Panza N; Pacilio G; Salvatore M
Nucl Med Commun; 1988 May; 9(5):347-56. PubMed ID: 2842708
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.
Camera L; Del Vecchio S; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
Eur J Nucl Med; 1991; 18(4):269-73. PubMed ID: 2070805
[TBL] [Abstract][Full Text] [Related]
4. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.
Del Vecchio S; Camera L; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
Int J Rad Appl Instrum B; 1991; 18(1):85-7. PubMed ID: 2010311
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe.
Bell J; Mojzisik C; Hinkle G; Derman H; Schlom J; Martin E
Obstet Gynecol; 1990 Oct; 76(4):607-11. PubMed ID: 2216188
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study of radioimmunoimaging by 131I-COC183B2 monoclonal antibody in patients with epithelial ovarian cancer.
Qian HN; Feng J; Cui H; Gao BS; Qin SL; Fu TY; Wei P; Fu ZY; Gao SM; Yang ZY
Chin Med J (Engl); 1991 Feb; 104(2):109-13. PubMed ID: 1874008
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
8. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer.
Shepherd JH; Granowska M; Britton KE; Mather S; Epenetos AA; Ward BG; Slevin M
Br J Obstet Gynaecol; 1987 Feb; 94(2):160-7. PubMed ID: 3828255
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas.
Qian HN; Feng J; Cui H; Fu TY; Wei P; Fu ZY
Chin Med J (Engl); 1989 Nov; 102(11):839-43. PubMed ID: 2517724
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
11. Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer.
Davies JO; Davies ER; Howe K; Jackson P; Pitcher E; Randle B; Sadowski C; Stirrat GM; Sunderland CA
J R Soc Med; 1985 Nov; 78(11):899-905. PubMed ID: 3906119
[TBL] [Abstract][Full Text] [Related]
12. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report.
Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K
Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532
[TBL] [Abstract][Full Text] [Related]
13. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
14. A simple and sensitive assay for determination of human anti-idiotypic anti-B72.3 antibodies, which is not affected by the presence of tumour-associated glycoprotein 72.
Reinsberg J; Schmolling J; Ackermann D
Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):237-44. PubMed ID: 8721411
[TBL] [Abstract][Full Text] [Related]
15. [Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma].
Barzen G; Cordes M; Langer M; Friedman W; Mayr AC; Felix R
Rofo; 1990 Jul; 153(1):85-91. PubMed ID: 2166319
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancer.
Haisma HJ; Moseley KR; Battaile AI; Griffiths TC; Zurawski VR; Knapp RC
Int J Cancer Suppl; 1988; 2():109-13. PubMed ID: 3162437
[TBL] [Abstract][Full Text] [Related]
18. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36.
Symonds EM; Perkins AC; Pimm MV; Baldwin RW; Hardy JG; Williams DA
Br J Obstet Gynaecol; 1985 Mar; 92(3):270-6. PubMed ID: 3978057
[TBL] [Abstract][Full Text] [Related]
20. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Simpson J; Schlom J
Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
